Proton Pump Inhibitors Use in Patients With Psoriasis
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Proton pump inhibitors act in blocking acid secretion and also have antioxidant and
anti-inflammatory properties. For that mechanisms possibly PPIs may have an anti-inflammatory
action with improvement in skin lesions in patients with psoriasis.